Skip to main content
HR 1827 118th Congress House

Pausing Enhanced Pandemic Pathogen Research Act of 2023

Official title: To prohibit the National Institutes of Health from conducting or supporting certain gain-of-function research, and for other purposes.

Introduced: March 28, 2023 Introduced by: Carter, Earl L. "Buddy" Republican · Georgia See on congress.gov
Health Infectious and parasitic diseasesMedical researchNational Institutes of Health (NIH)Research administration and funding
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2023
Referred to the Subcommittee on Health.
Mar 28, 2023
Referred to the House Committee on Energy and Commerce.
Mar 28, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 7, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Pausing Enhanced Pandemic Pathogen Research Act of 2023

This bill generally prohibits the National Institutes of Health from conducting or supporting gain-of-function research through March 30, 2028. The bill defines gain-of-function research as any research that could enhance the transmissibility, virulence, or pathogenicity of any pathogen or non-pathogen agent in a way that could lead to (1) moderate or high transmissibility, virulence, or pathogenicity in human populations; (2) significant morbidity or mortality in humans; or (3) severe threats to public health or U.S. national security.

The prohibition does not apply to the characterization or testing of naturally occurring influenza virus or coronavirus unless the characterization or testing could increase viral pathogenicity or transmissibility.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 1 Republican 2
Lesko, Debbie
· May 11, 2023
 R
Reschenthaler, Guy
Pennsylvania · Apr 26, 2023
 R
Brecheen, Josh
Oklahoma · Apr 25, 2023
 D
Cuellar, Henry
Texas · Mar 28, 2023
Gallagher, Mike
· Mar 28, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1827: Pausing Enhanced Pandemic Pathogen Research Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1827/
MLA
"H.R. 1827: Pausing Enhanced Pandemic Pathogen Research Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1827/.
Bluebook (legal)
H.R. 1827, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1827/.
Markdown link
[H.R. 1827: Pausing Enhanced Pandemic Pathogen Research Act of 2023](https://openamerica.io/bill/118-HR-1827/)
Report a problem